WASHINGTON (AP) — U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily ... The first-of-its-kind clinical trial has been ...

The FDA will allow a trial of gene-edited pig livers as a dialysis-like treatment for people with sudden liver failure. (AP) Non-invasive spleen stiffness measurement in patients with compensated ...

Treatment options are limited for those with sudden liver failure and the condition has a death rate as high as 50%. HealthDay News — A new clinical trial will soon test if a pig liver can help ...

The Food and Drug Administration has approved a gene edit used to create pigs resistant to Porcine Reproductive and Respiratory Syndrome, or PRRS. The Pig Improvement Co., a subsidiary of Genus ...

QUEENSBURY, N.Y., April 28, 2025--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today ...

The US Food and Drug ... trial to test whether genetically modified pig livers can be used safely to treat people with organ failure. In the initial phase of the trial, four people with severe ...

Approval was based on favorable safety, efficacy and tolerability data from two clinical trials. The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine ...

Tim Andrews knew that he needed dialysis to manage his end-stage kidney disease, but over months of treatment, he started to ...